Abstract
Based on current knowledge, it is evident that epigenetic mechanisms contribute to the pathogenesis of type 2 diabetes and its complications. Transient hyperglycemia induces recruitment of the SET7 methyltransferase and H3K4 monomethylation in the promoter of the NF-κB subunit p65 and subsequent expression of NF-κB-dependent genes involved in the progression of diabetic complications.
PREP1 is a gene having a role in insulin sensitivity of glucose transport, as its overexpression causes insulin resistance. In vitro and in vivo exposure to high glucose concentrations increased PREP1 expression levels. This event was preceded by recruitment of NF-κB p65 at the SET7 5′-flanking region, along with recruitment of the SET7 histone methyltransferase and p300 histone acetyltransferase to the same regulatory region. Indeed, high glucose exposure was associated with increased histone H3 Lys4 mono- and dimethylation and Lys9/14 acetylation at the PREP1 promoter. NF-κB recruitment is fundamental in driving the action of epigenetic enzymes at the PREP1 5′ regulatory region, since different NF-κB pharmacologic inhibitors attenuated t3hese effects.
The consequence of PREP1 overexpression is the recruitment of the repressor complex myocyte enhancer factor 2 (MEF2)/histone deacetylase 5 (HDAC5) at the GLUT4 promoter that leads to reduction of its expression. Thus, PREP1 can be considered as a target downstream of NF-κB that is capable to induce insulin resistance in response to hyperglycemia and inflammatory hits. Histone modifications at the PREP1 gene may be responsible for insulin resistance in individuals with type 2 diabetes.
Similar content being viewed by others
Abbreviations
- (p)AMPK:
-
(Phosphorylated)5′AMP-activated protein kinase
- AcH3:
-
Histone H3 acetylation
- AGEs:
-
Advanced glycation end products
- ChIP:
-
Chromatin immunoprecipitation
- GLUT4:
-
Glucose transporter type 4
- H3K4me1:
-
Histone H3 Lys4 monomethylation
- H3K4me2:
-
Histone H3 Lys4 dimethylation
- HDAC5:
-
Histone deacetylase 5
- HG:
-
High glucose
- HMOX1:
-
Heme oxygenase 1
- MCP1:
-
Monocyte chemoattractant protein-1
- MEF2:
-
Myocyte enhancer factor 2
- NF-κB:
-
Nuclear factor κ light chain enhancer of activated B cells
- NG:
-
Normal glucose
- PREP1:
-
Pbx-regulating protein 1
- ROS:
-
Reactive oxygen species
- SET7/9:
-
Su(var)3-9, enhancer-of-zeste, trithorax domain-containing lysine methyltransferase 7
- STZ:
-
Streptozotocin
- T2DM:
-
Type 2 diabetes mellitus
- TALE:
-
Three-amino acid loop extension
- VCAM1:
-
Vascular cell adhesion molecule 1
References
Advance Collaborative Group, Patel A, Macmahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560–2572
Andersen PH, Lund S, Vestergaard H, Junker S, Kahn BB, Pedersen O (1993) Expression of the major insulin regulable glucose transporter (GLUT4) in skeletal muscle of non insulin-dependent diabetic patients and healthy subjects before and after insulin infusion. J Clin Endocrinol Metab 77:27–32
Baker RG, Hayden MS, Ghosh S (2011) NF-kB, inflammation, and metabolic disease. Cell Metab 13:11–22
Berthelsen J, Kilstrup-Nielsen C, Blasi F, Mavilio F, Zappavigna V (1999) The subcellular localization of PBX1 and EXD proteins depends on nuclear import and export signals and is modulated by association with PREP1 and hth. Genes Dev 13:946–953
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820
Burglin TR (1997) Analysis of TALE superclass homeobox genes (MEIS, PBC, KNOX, Iroquois, TGIF) reveals a novel domain conserved between plants and animals. Nucleic Acids Res 25:4173–4180
Ceriello A, Inhnat MA, Thorpe JE (2009) Clinical review 2: the “metabolic memory”: is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab 94:410–415
Ciccarelli M, Vastolo V, Albano L, Lecce M, Cabaro S, Liotti A, Longo M, Oriente F, Russo GL, Macchia PE, Formisano P, Beguinot F, Ungaro P (2015) Glucose-induced expression of the homeotic transcription factor PREP1 is associated with histone post-translational modifications in skeletal muscle. Diabetologia 59:176–186
Cooper ME, El-Osta A (2010) Epigenetics: mechanisms and implications for diabetic complications. Circ Res 107:1403–1413
Deering TG, Ogihara T, Trace AP, Maier B, Mirmira RG (2009) Methyltransferase SET7/9 maintains transcription and euchromatin structure at islet-enriched genes. Diabetes 58:185–193
Dhayalan A, Kudithipudi S, Rathert P, Jeltsch A (2011) Specificity analysis-based identification of new methylation targets of the SET7/9 protein lysine methyltransferase. Chem Biol 18:111–120
El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M (2008) Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 205:2409–2417
Ferretti E, Villaescusa JC, Di Rosa P, Fernandez-Diaz LC, Longobardi E, Mazzieri R, Miccio A, Micali N, Selleri L, Ferrari G, Blasi F (2006) Hypomorphic mutation of the TALE gene PREP1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype. Mol Cell Biol 26:5650–5662
Jones PA, Takai D (2001) The role of DNA methylation in mammalian epigenetics. Science 293:1068–1070
Keating ST, El-Osta A (2013) Epigenetic changes in diabetes. Clin Genet 84:1–10
Keating ST, Plutzky J, El-Osta A (2016) Epigenetic changes in diabetes and cardiovascular risk. Circ Res 118:1706–1722
King GL, Brownlee M (1996) The cellular and molecular mechanism of diabetic complications. Endocrinol Metab Clin N Am 25:255–270
Kowluru RA, Kowluru V, Xiong Y, Ho YS (2006) Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radic Biol Med 41:1191–1196
Mcgee SL, Hargreaves M (2004) Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle. Diabetes 53:1208–1214
Mcgee SL, van Denderen BJW, Howlett KF, Mollica J, Schertzer JD, Kemp BE, Hargreaves M (2008) AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes 57:860–867
Milicevic Z, Raz I, Beattle SD, Campaigne BN, Sarwat S, Gromniak E, Kowalska I, Galic E, Tan M, Hanefeld M (2008) Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia. Diabetes Care 31:S155–S160
Nishikawa T, Edelstein D, Brownlee M (2000) The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl 77:S26–S30
Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD, Cleary ML (1990) Chromosomal translocation t(1:19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60:535–545
Okabe J, Orlowski C, Balcerczyk A, Tikellis C, Thomas MC, Cooper ME, El-Osta A (2012) Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells. Circ Res 110:1067–1076
Oriente F, Fernandez Diaz LC, Miele C, Iovino S, Mori SVMD, Troncone G, Cassese A, Formisano P, Blasi F, Beguinot F (2008) Prep1 deficiency induces protection from diabetes and increased insulin sensitivity through a p160-mediated mechanism. Mol Cell Biol 28:5634–5645
Pirola L, Balcerczyk A, Okabe J, El-Osta A (2010) Epigenetic phenomena linked to diabetic complications. Nat Rev Endocrinol 6:665–675
Reddy MA, Natarajan R (2011) Epigenetic mechanisms in diabetic vascular complications. Cardiovasc Res 90:421–429
Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, Cui H, Feinberg AP, Lengauer C, Kinzler KW, Baylin SB, Vogelstein B (2002) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416:552–556
Schmidt A, Hori O, Brett J, Yan SD, Wautier JL, Stern D (1994) Cellular receptors for advanced glycation end products: implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14:1521–1528
Shen X, Zheng S, Metreveli NS, Epstein PN (2006) Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes 55:798–805
Steelman S, Moskow JJ, Muzynski K, North C, Druck T, Montgomery JC, Huebner KDIO, Buchberg AM (1997) Identification of a conserved family of meis-related homeobox genes. Genome Res 7:142–156
Tsao TS, Burcelin R, Katz EB, Huang L, Charron MJ (1996) Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 45:28–36
Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033
Zhang Y, Wada J, Hashimoto I, Eguchi J, Yasuhara A, Kanwar YS, Shikata K, Makino H (2006) Therapeutic approach for diabetic nephropathy using gene delivery of translocase of inner mitochondrial membrane 44 by reducing mitochondrial superoxide production. J Am Soc Nephrol 17:1090–1101
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this entry
Cite this entry
Albano, L., Macchia, P.E., Ungaro, P. (2017). Epigenetic and Metabolism: Glucose and Homeotic Transcription Factor PREP1 VRP Suggested Epigenetics and Metabolism. In: Patel, V., Preedy, V. (eds) Handbook of Nutrition, Diet, and Epigenetics. Springer, Cham. https://doi.org/10.1007/978-3-319-31143-2_8-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-31143-2_8-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-31143-2
Online ISBN: 978-3-319-31143-2
eBook Packages: Springer Reference MedicineReference Module Medicine